HKD 0.67
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 173.29 Million HKD | -19.77% |
2022 | 216 Million HKD | -23.45% |
2021 | 282.16 Million HKD | 48.75% |
2020 | 189.69 Million HKD | 29.26% |
2019 | 146.75 Million HKD | 24.92% |
2018 | 117.47 Million HKD | 2.92% |
2017 | 114.13 Million HKD | 7.64% |
2016 | 106.03 Million HKD | 17.19% |
2015 | 90.48 Million HKD | -23.87% |
2014 | 118.84 Million HKD | 14.14% |
2013 | 104.12 Million HKD | -8.15% |
2012 | 113.35 Million HKD | 1.95% |
2011 | 111.19 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 156.06 Million HKD | -9.95% |
2024 Q2 | 156.06 Million HKD | 0.0% |
2023 Q4 | 173.29 Million HKD | 0.0% |
2023 Q1 | 162.58 Million HKD | -24.73% |
2023 FY | 173.29 Million HKD | -19.77% |
2023 Q3 | 173.29 Million HKD | 6.59% |
2023 Q2 | 162.58 Million HKD | 0.0% |
2022 FY | 216 Million HKD | -23.45% |
2022 Q1 | 212.41 Million HKD | -24.72% |
2022 Q2 | 212.41 Million HKD | 0.0% |
2022 Q3 | 216 Million HKD | 1.69% |
2022 Q4 | 216 Million HKD | 0.0% |
2021 Q1 | 254.96 Million HKD | 34.41% |
2021 Q4 | 282.16 Million HKD | 0.0% |
2021 FY | 282.16 Million HKD | 48.75% |
2021 Q2 | 254.96 Million HKD | 0.0% |
2021 Q3 | 282.16 Million HKD | 10.67% |
2020 Q2 | 174.52 Million HKD | 0.0% |
2020 FY | 189.69 Million HKD | 29.26% |
2020 Q4 | 189.69 Million HKD | 0.0% |
2020 Q3 | 189.69 Million HKD | 8.69% |
2020 Q1 | 174.52 Million HKD | 18.92% |
2019 Q4 | 146.75 Million HKD | 14.85% |
2019 FY | 146.75 Million HKD | 24.92% |
2019 Q3 | 127.77 Million HKD | 21.03% |
2019 Q2 | 105.57 Million HKD | -10.13% |
2019 Q1 | 117.47 Million HKD | 9.24% |
2018 Q1 | 114.13 Million HKD | 7.55% |
2018 FY | 117.47 Million HKD | 2.92% |
2018 Q3 | 114.98 Million HKD | 0.0% |
2018 Q4 | 107.53 Million HKD | -6.48% |
2017 Q2 | 79.42 Million HKD | -25.1% |
2017 Q4 | 106.12 Million HKD | 23.22% |
2017 FY | 114.13 Million HKD | 7.64% |
2017 Q3 | 86.12 Million HKD | 8.44% |
2017 Q1 | 106.03 Million HKD | 6.22% |
2016 Q1 | 90.48 Million HKD | 7.92% |
2016 Q4 | 99.82 Million HKD | 32.67% |
2016 Q3 | 75.23 Million HKD | 6.47% |
2016 FY | 106.03 Million HKD | 17.19% |
2016 Q2 | 70.66 Million HKD | -21.9% |
2015 Q2 | 95.88 Million HKD | -19.32% |
2015 Q1 | 118.84 Million HKD | 3.83% |
2015 Q4 | 83.83 Million HKD | -17.14% |
2015 FY | 90.48 Million HKD | -23.87% |
2015 Q3 | 101.18 Million HKD | 5.53% |
2014 Q2 | 108.01 Million HKD | 3.74% |
2014 Q4 | 114.46 Million HKD | 2.44% |
2014 Q3 | 111.73 Million HKD | 3.44% |
2014 Q1 | 104.12 Million HKD | 2.12% |
2014 FY | 118.84 Million HKD | 14.14% |
2013 Q4 | 101.96 Million HKD | -9.45% |
2013 Q3 | 112.6 Million HKD | 11.97% |
2013 FY | 104.12 Million HKD | -8.15% |
2013 Q2 | 100.56 Million HKD | -11.29% |
2013 Q1 | 113.35 Million HKD | 2.1% |
2012 Q4 | 111.03 Million HKD | 0.0% |
2012 FY | 113.35 Million HKD | 1.95% |
2012 Q2 | - HKD | 0.0% |
2011 FY | 111.19 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Starlite Holdings Limited | 266.35 Million HKD | 34.937% |
Litu Holdings Limited | 537.22 Million HKD | 67.742% |
Touyun Biotech Group Limited | 586.26 Million HKD | 70.441% |
Champion Alliance International Holdings Limited | 99.22 Million HKD | -74.645% |